百诚医药:自研转化高增长,新签订单增长较为稳健
Bio-S(301096) 信达证券·2024-08-17 07:07
| --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...